Cargando…
Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men. Various strategies for targeted biopsy based on multiparametric magnetic resonance imaging (mp-MRI) have emerged, which may improve the accuracy of detecting clinically significant PCa in recent years. AIM: To investigate...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717504/ https://www.ncbi.nlm.nih.gov/pubmed/35071549 http://dx.doi.org/10.12998/wjcc.v9.i36.11183 |
_version_ | 1784624546640297984 |
---|---|
author | Pang, Cheng Wang, Miao Hou, Hui-Min Liu, Jian-Yong Zhang, Zhi-Peng Wang, Xuan Zhang, Ya-Qun Li, Chun-Mei Zhang, Wei Wang, Jian-Ye Liu, Ming |
author_facet | Pang, Cheng Wang, Miao Hou, Hui-Min Liu, Jian-Yong Zhang, Zhi-Peng Wang, Xuan Zhang, Ya-Qun Li, Chun-Mei Zhang, Wei Wang, Jian-Ye Liu, Ming |
author_sort | Pang, Cheng |
collection | PubMed |
description | BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men. Various strategies for targeted biopsy based on multiparametric magnetic resonance imaging (mp-MRI) have emerged, which may improve the accuracy of detecting clinically significant PCa in recent years. AIM: To investigate the diagnostic efficiency of a template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy in detecting PCa. METHODS: Data from patients with an increasing prostate-specific antigen (PSA) level but less than 20 ng/mL and at least one lesion suspicious for PCa on MRI from December 2015 to June 2018 were retrospectively analyzed. All patients underwent cognitive fusion transperineal template-guided targeted biopsy followed by randomized biopsy outside the targeted area. A total of 127 patients with complete data were included in the final analysis. A multivariable logistic regression analysis was conducted, and a two-sided P < 0.05 was considered statistically significant. RESULTS: PCa was detected in 66 of 127 patients, and 56 cases presented clinically significant PCa. Cognitive fusion targeted biopsy alone detected 59/127 cases of PCa, specifically 52/59 cases with clinically significant PCa and 7/59 cases with clinically insignificant PCa. A randomized biopsy detected seven cases of PCa negative on targeted biopsy, and four cases had clinically significant PCa. PSA density (OR: 1.008, 95%CI: 1.003-1.012, P = 0.001; OR: 1.006, 95%CI: 1.002-1.010, P = 0.004) and Prostate Imaging-Reporting and Data System (PI-RADS) scores (both P < 0.001) were independently associated with the results of cognitive fusion targeted biopsy combined with randomized biopsy and targeted biopsy alone. CONCLUSION: This single-centered study proposed a feasible template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy. Patients with higher PSAD and PI-RADS scores were more likely to be diagnosed with PCa. |
format | Online Article Text |
id | pubmed-8717504 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-87175042022-01-20 Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer Pang, Cheng Wang, Miao Hou, Hui-Min Liu, Jian-Yong Zhang, Zhi-Peng Wang, Xuan Zhang, Ya-Qun Li, Chun-Mei Zhang, Wei Wang, Jian-Ye Liu, Ming World J Clin Cases Retrospective Study BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men. Various strategies for targeted biopsy based on multiparametric magnetic resonance imaging (mp-MRI) have emerged, which may improve the accuracy of detecting clinically significant PCa in recent years. AIM: To investigate the diagnostic efficiency of a template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy in detecting PCa. METHODS: Data from patients with an increasing prostate-specific antigen (PSA) level but less than 20 ng/mL and at least one lesion suspicious for PCa on MRI from December 2015 to June 2018 were retrospectively analyzed. All patients underwent cognitive fusion transperineal template-guided targeted biopsy followed by randomized biopsy outside the targeted area. A total of 127 patients with complete data were included in the final analysis. A multivariable logistic regression analysis was conducted, and a two-sided P < 0.05 was considered statistically significant. RESULTS: PCa was detected in 66 of 127 patients, and 56 cases presented clinically significant PCa. Cognitive fusion targeted biopsy alone detected 59/127 cases of PCa, specifically 52/59 cases with clinically significant PCa and 7/59 cases with clinically insignificant PCa. A randomized biopsy detected seven cases of PCa negative on targeted biopsy, and four cases had clinically significant PCa. PSA density (OR: 1.008, 95%CI: 1.003-1.012, P = 0.001; OR: 1.006, 95%CI: 1.002-1.010, P = 0.004) and Prostate Imaging-Reporting and Data System (PI-RADS) scores (both P < 0.001) were independently associated with the results of cognitive fusion targeted biopsy combined with randomized biopsy and targeted biopsy alone. CONCLUSION: This single-centered study proposed a feasible template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy. Patients with higher PSAD and PI-RADS scores were more likely to be diagnosed with PCa. Baishideng Publishing Group Inc 2021-12-26 2021-12-26 /pmc/articles/PMC8717504/ /pubmed/35071549 http://dx.doi.org/10.12998/wjcc.v9.i36.11183 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Pang, Cheng Wang, Miao Hou, Hui-Min Liu, Jian-Yong Zhang, Zhi-Peng Wang, Xuan Zhang, Ya-Qun Li, Chun-Mei Zhang, Wei Wang, Jian-Ye Liu, Ming Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
title | Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
title_full | Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
title_fullStr | Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
title_full_unstemmed | Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
title_short | Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
title_sort | cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717504/ https://www.ncbi.nlm.nih.gov/pubmed/35071549 http://dx.doi.org/10.12998/wjcc.v9.i36.11183 |
work_keys_str_mv | AT pangcheng cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT wangmiao cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT houhuimin cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT liujianyong cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT zhangzhipeng cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT wangxuan cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT zhangyaqun cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT lichunmei cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT zhangwei cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT wangjianye cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer AT liuming cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer |